Last updated on September 2016

ACTH for Fatigue in Multiple Sclerosis Patients

Brief description of study

This is a study of Acthar gel (ACTH) in patients with relapsing multiple sclerosis who are experiencing chronic fatigue.

Detailed Study Description

This is a multi-center, randomized, double-blind, placebo-controlled study to demonstrate the safety, tolerability, and effect of ACTH on fatigue in patients with relapsing multiple sclerosis (RMS). The primary objective of this study is to assess the efficacy of ACTH versus placebo in reducing fatigability in patients with RMS. Secondary objectives include assessment of the tolerability and safety of twice-weekly ACTH treatment vs. placebo and evaluation of ACTH on depression, sleepiness, and quality of life measures and correlations between these measures.

Clinical Study Identifier: NCT02315872


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Christopher LaGanke, MD

North Central Neurology Associates, PC
Cullman, AL United States
  Connect »

Walter Carlini, MD, PhD

Providence Medical Group - Medford Neurology
Medford, OR United States
  Connect »

Hannah Voss

Providence St. Vincent Medical Center
Portland, OR United States
  Connect »

John Foley, MD

Rocky Mountain Research Group
Salt Lake City, UT United States
  Connect »

James Bowen, MD

Swedish Medical Center
Seattle, WA United States
  Connect »

John Huddlestone, MD

MultiCare Health System -- Institute for Research and Innovation
Tacoma, WA United States
  Connect »